RBM17 and acute myeloid leukemia: In total, we identified 832 differentially expressed genes (false discovery rate (FDR) ≤ 0.05, flod change (FC) ≥ 2 or ≤0.5), including 336 transcripts more abundant, and 496 transcripts less abundant in AML patient samples with higher RBM17 expression (Fig. 1h).